Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : SNY crawled date : 2021 - 06 - 17 save search
$10+ Billion Blood Glucose Monitoring Devices Global Market to 2026 - Increasing Awareness About Point of Care Testing Presents Opportunities
Published: 2021-06-17 (Crawled : 21:00) - prnewswire.com
MDT | $80.23 0.13% -0.05% 7.5M
|
Health Technology
|
| O: -1.29%
H: 0.62%
C: -0.29%
JNJ | $147.59 0.05% -0.18% 6.4M
|
Health Technology
|
| O: -1.18%
H: 0.56%
C: -0.79%
FMC | $56.74 -0.02% -0.07% 1.6M
|
Process Industries
|
| O: -1.33%
H: 0.4%
C: -3.77%
LLY | $750.77 -0.12% -0.23% 1.8M
|
Health Technology
|
| O: -0.8%
H: 0.28%
C: -0.85%
ABT | $108.89 -0.2% 0.0% 3.4M
|
Health Technology
|
| O: -1.46%
H: 1.23%
C: 0.3%
SNY | $46.22 0.63% 0.63% 1.7M
|
Health Technology
|
| O: -1.9%
H: 1.38%
C: 1.21%
DXCM | $134.56 -1.16% -1.16% 1.6M
|
Health Technology
|
| O: -0.13%
H: 1.77%
C: 1.55%
blood test device
Global Mycosis Fungoides Market (2021 to 2029) - Featuring Bayer, Elorac and Sanofi Among Others
Published: 2021-06-17 (Crawled : 21:00) - prnewswire.com
SNGX | $0.4673 21.03% 17.38% 130M
|
Health Technology
|
| O: -1.67%
H: 0.85%
C: -5.08%
SNY | $46.22 0.63% 0.63% 1.7M
|
Health Technology
|
| O: -1.9%
H: 1.38%
C: 1.21%
DUPIXENT (dupilumab injection) pre-filled pen now available in Canada, providing convenient self-administration option for people with type 2 inflammatory diseases
Published: 2021-06-17 (Crawled : 15:00) - biospace.com/
SNY | $46.22 0.63% 0.63% 1.7M
|
Health Technology
|
| O: -0.98%
H: 0.77%
C: 0.65%
disease injection dupixent
CytoReason Collaborates with Sanofi, Using its AI Technology to Gain Better Understanding of Disease Mechanisms
Published: 2021-06-17 (Crawled : 15:00) - biospace.com/
SNY | $46.22 0.63% 0.63% 1.7M
|
Health Technology
|
| O: -0.98%
H: 0.77%
C: 0.65%
disease technology collaboration air technology
Athletico Taps YOOBIC Digital Workplace to Enable Growth Aspirations
Published: 2021-06-17 (Crawled : 13:00) - prnewswire.com
SNY | $46.22 0.63% 0.63% 1.7M
|
Health Technology
|
| O: -0.98%
H: 0.77%
C: 0.65%
growth
Newly licensed US manufacturing facility to increase availability of Fluzone® High-Dose Quadrivalent (influenza vaccine)
Published: 2021-06-17 (Crawled : 12:00) - biospace.com/
SNY | $46.22 0.63% 0.63% 1.7M
|
Health Technology
|
| O: -0.98%
H: 0.77%
C: 0.65%
vaccine license influenza
Rancho Santa Fe Bio, Inc. Enters into Worldwide Exclusive License Agreement with Sanofi for Ataciguat
Published: 2021-06-17 (Crawled : 11:00) - biospace.com/
SNY | $46.22 0.63% 0.63% 1.7M
|
Health Technology
|
| O: -0.98%
H: 0.77%
C: 0.65%
license
Gainers vs Losers
| 47% | 53% |
Top 10 Gainers
KAVL | $6.3 135.96% 57.45% 44M
|
Wholesale Trade
PXMD | $0.74 79.7% 44.16% 4.5M
|
Health Technology
DYNT | $0.3704 -5.27% 43.09% 1.6M
|
Health Technology
LGVN P 3 d | $2.93 73.37% 42.52% 56M
|
HUBC | $1.95 50.0% 32.99% 73M
|
n/a
SPCB | $0.4044 46.52% 31.75% 130M
|
Electronic Technology
ONVO | $1.35 33.65% 24.62% 53M
|
Health Technology
OMQS | $0.7038 35.35% 24.3% 3.5M
|
Professional, Scientific, and T...
SNPO | $10.555 29.67% 22.88% 4M
|
EEIQ | $1.16 27.46% 20.86% 6.9K
|
Educational Services
Your saved searches
Save your searches and get alerts when important news are released.